Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.

Authors :: Verschraegen CF
Vincent M
Abbruzzese JL
Siegler D
Kavanagh JJ
Loyer E
Kudelka AP
Rubin E
Source :: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2000; Vol. 922, pp. 345-8.
Publication Year :: 2000

Subjects :: Antineoplastic Combined Chemotherapy Protocols therapeutic use
Camptothecin administration & dosage
Camptothecin adverse effects
Camptothecin analogs & derivatives
Cisplatin administration & dosage
Cisplatin adverse effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Synergism
Humans
Antineoplastic Combined Chemotherapy Protocols adverse effects
Neoplasms drug therapy

Full Text Access

Tools